Chemoprevention for colorectal cancer

Crit Rev Oncol Hematol. 2000 Mar;33(3):199-219. doi: 10.1016/s1040-8428(99)00075-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenoma / genetics
  • Adenoma / pathology
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticarcinogenic Agents / therapeutic use*
  • Antioxidants / therapeutic use
  • Apoptosis
  • Arachidonic Acids / metabolism
  • Bile Acids and Salts / metabolism
  • Biomarkers
  • Calcium / therapeutic use
  • Cell Cycle
  • Cell Transformation, Neoplastic / chemically induced
  • Clinical Trials as Topic
  • Colonic Polyps / genetics
  • Colonic Polyps / pathology
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / prevention & control*
  • DNA Methylation
  • DNA Repair / genetics
  • Eflornithine / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Estrogens / pharmacology
  • Estrogens / therapeutic use
  • Free Radical Scavengers / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Mice
  • Ornithine Decarboxylase Inhibitors
  • Patient Compliance
  • Patient Selection
  • Polyamines / metabolism
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology
  • Pyrazines / therapeutic use
  • Rats
  • Retinoids / therapeutic use
  • Thiones
  • Thiophenes
  • Tumor Cells, Cultured
  • Vitamins / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticarcinogenic Agents
  • Antioxidants
  • Arachidonic Acids
  • Bile Acids and Salts
  • Biomarkers
  • Enzyme Inhibitors
  • Estrogens
  • Free Radical Scavengers
  • Ornithine Decarboxylase Inhibitors
  • Polyamines
  • Pyrazines
  • Retinoids
  • Thiones
  • Thiophenes
  • Vitamins
  • oltipraz
  • Calcium
  • Eflornithine